Posted inNew Drugs
Linvoseltamab‑gcpt (Lynozyfic) was approved by FDA for Multiple Myeloma: Uses, Dosage & Cost Explained
🌟 Approval Milestone & Official Resources On July 2, 2025, the U.S. Food and Drug Administration (FDA) granted accelerated approval under the brand name Lynozyfic (linvoseltamab‑gcpt) for adult patients with…
